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Diffuse Alveolar Hemorrhage in a 39-year-old Woman: Unusual 
Initial Presentation of Microscopic Polyangiitis
Jae  Jun  Kim,  M.D.*,  Jae-Kil  Park,  M.D.*,  Young-Pil  Wang,  M.D.*,  Hyung  Joo  Park,  M.D.*, 
Sook-Whan  Sung,  M.D.*,  Do-Yeon  Kim,  M.D.*
Microscopic polyangiitis (MPA) is a necrotizing vasculitis involving the small vessels without granulomatous inflam-
mation. Most MPA initially presents with renal involvement without pulmonary involvement. Isolated and initially pre-
senting alveolar hemorrhage is very rare. The patient was a 39-year-old female with a progressive cough, dyspnea, 
and blood-tinged sputum for the previous 5 days. We determined that her condition was MPA though VATS lung 
biopsy and renal biopsy. After 2 months of steroid therapy, the chest lesions had improved. We report here a 
rare case of MPA with isolated and initial involvement of the lung with a review of the literature. 




A  39-year-old  woman  visited  the  emergency  room  with  a 
progressive  cough,  dyspnea,  and  blood-tinged  sputum  for  the 
previous  5  days.  The  patient  did  not  use  tobacco  or  alcohol, 
nor  did  she  have  any  specific  medical  history.  At  initial  pre-
sentation,  her  blood  pressure  was  107/54  mmHg,  pulse  rate 
74  beats  per  minute,  respiration  rate  22  breaths  per  minute, 
and  body  temperature  36.8
oC.  The  patient  was  wide  awake 
and well oriented. There were no other suggestive symptoms. 
Here  CBC  count  was  as  follows:  white  blood  cell  count 
8,420/mm
3  (75.1%  granulocytes,  17.7%  lymphocytes,  5.6% 
monocytes and 0.4% eosinophils), hematocrit 25.2 mg/dL and 
platelets  374  K/mm
3.  Her  serum  chemistry  and  liver  function 
were normal. There was no serologic evidence of hepatitis. A 
urine  analysis  was  non-specific. A  c h e s t  P A  r e v e a l e d  a n  i n -
creased opacity throughout both lower lung fields and a chest 
CT  revealed  extensive  ground-glass  opacities  in  both  whole 
lung  fields  without  any  lymphadenopathy  (Fig.  1).  A  sputum 
study  was  negative  for  acid-fast  bacilli  and  blood  culture 
findings  were  negative.  Bronchoscopy  findings  were  compat-
ible  with  pulmonary  alveolar  hemorrhage  at  RML  and  RLL. 
At  first  we  considered  the  case to  be  a  simple alveolar  hem-
orrhage  associated  with  pneumonia,  so  we  treated  her  con-
servatively  and  her  symptoms,  including  hemoptysis,  impro-
ved. On the 5th day from admission, her urine color changed 
abruptly  to  bloody  and  we  performed  further  evaluation  for 
simultaneous  hematuria  and  hemoptysis.  Serum  protein  elec-
trophoresis  revealed a decrease  in total pr otein alb umin bu t a 
normal  immunotyping  pattern.  There  was  no  serologic  evi-
dence  of  hepatitis.  Serum  antinuclear  antibody,  anti-glomer-
ular  basement  membrane  antibody  (anti-GBM),  mycoplasma Diffuse Alveolar Hemorrhage Due to MPA
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Fig. 1. Chest X-ray (A) and Chest 
CT (B) showed extensive ground- 
glass opacities in both whole lung 
fields without any lymphadenopathy.
Fig. 2. Lung specimen showed intraalveolar hemorrhage with ag-
gregation of pigment-laden macrophages and a few neutrophils 
suggesting capillaritis (hematoxylin-eosin stain, x100).
pneumonia,  and  mycoplasma  tuberculosis  titers  were  all  neg-
ative,  Complement  levels  (C3,  C4,  and  CH50)  were  normal 
but  anti  MPO  antibody  (＞100)  and  p-ANCA  (1 : 160)  were 
positive.  For  accurate  diagnosis,  we  performed  a  VATS  lung 
biopsy  on  the  9th  hospital  day  and  renal  biopsy  on  the  14th 
hospital  day.  The  pathology  report  showed  the  lung  lesion 
was  intraralveolar  hemorrhage  suggesting  capillaritis  and  the 
kidney lesion was focal segmental necrotizing glomeruloneph-
ritis  without  antibody  deposition  at  the  capillary  basement 
membrane (Fig. 2, 3). Therefore, we diagnosed this condition 
as  microscopic  polyangiitis  presenting  with  initial  pulmonary 
involvement  and  we  started  her  on  steroid  therapy.  After  2 
months of steroid therapy, her chest lesions had improved but 
hematuria  remained  (Fig.  4).  More  treatment  will  be  needed.
DISCUSSION
There  are  many  causes  for  hemoptysis  or  diffuse  alveolar 
hemorrhage.  One  of  them  is  vasculitis,  which  is  rarely  en-
countered  in  the  thoracic  surgery  field  [1,2].  Vasculitis  is  an 
inflammatory  destructive  process  affecting  blood  vessels  and 
surrounding  tissue  through  diverse  mechanisms.  Microscopic 
polyangiitis (below MPA) is a necrotizing vasculitis involving 
the  small  vessels  without  granulomatous  inflammation  [3]. 
MPA  is  the  most  common  antineutrophilic  cytoplasmic  anti-
body  (ANCA)-associated  small  vessel  vasculitis  and  is  char-
acterized  by  a  lack  of  immune  deposits  in  the  involved  ves-
sels [1,4]. The incidence of MPA is about 1 : 100,000 with a 
slight  predominance  in  men.  The  mean  age  of  onset  is  about 
40  or  50  years  [4].  The  kidney  is  the  most  frequently  in-
volved  organ  in  90%  of  patients.  The  lung  is  involved  in 
22%, and alveolar hemorrhage occurs in 11% [4,5]. Other or-
gans and systems including the skin, GI tract, musculoskeletal 
system, heart, and nervous system can also be involved [3,6]. 
Most  MPA  initially  presents  as  renal  involvement  without 
pulmonary involvement, while isolated and initially presenting 
alveolar  hemorrhage  is  very  rare  [4].  The  cause  of  MPA  re-
mains  unknown,  but  some  researchers  have  proposed  genetic, 
environmental,  and  immunologic  factors  such  as  ANCA  in 
the  pathogenesis  of  MPA  [1,4].  Chest  radiographic  findings Jae Jun Kim, et al
− 450  −
Fig. 3. Renal specimen shown was focal segmental necrotizing glomerulonephritis without antibody deposition at the capillary basement 
membrane (A: hematoxylin-eosin stain, ×400, B: immunofluorescence stain, ×400).
Fig. 4. Chest X-ray after steroid therapy for 2 months showed 
improved infiltration in both lung fields. 
consist of ground-glass opacity, consolidation, thickened bron-
chovascular  bundles  and  a  honeycomb  appearance  caused  by 
alveolar  hemorrhage  [2,4].  An  ANCA  test  is  used  to  aid  in 
diagnosis and to monitor inflammatory activity in vaculitis in-
cluding  MPA,  Wegener’s  granulomatosis,  and  Churg-Strauss 
syndrome  [1,3].  Previous  studies  have  reported  that  50%  to 
80%  of  MPA  patients  test  positive  for  ANCA  [3,5].
Because  lung  biopsy  can  aggravate  conditions  of  critically 
ill  patients  and  pulmonary  involv e m e n t  u s u a l l y  f o l l o w s  a f t e r  
renal  involvement,  lung  biopsy  is  not  usually  recommended 
in the case of vasculitis-associated alveolar hemorrhage if the 
diagnosis  can  be  obtained  by  biopsy  of  other  organs  and  by 
a serum immunology study [1,4]. In our case, because of the 
unusual  presentations,  specifically,  initial  pulmonary  involve-
ment  without  renal  involvement  and  hemoptysis  improvement 
after conservative treatment, we needed a lung biopsy for ac-
curate diagnosis. Lung specimens  of MPA usually show only 
necrosis,  nonspecific  inflammation,  and  hemorrhage  pulmo-
nary  capillaritis  [1,4].  Renal  specimens  usually  show  focal 
segmental necrotizing glomerulonephritis without any immune 
deposition  [1,4].  Our  lung  specimen  showed  intraalveolar 
hemorrhage  with  aggregation  of  pigment-laden  macrophages 
and  a  few  neutrophils,  suggesting  capillaritis  and  organizing 
pneumonia,  and  our  renal  specimen  showed  focal  segmental 
necrotizing glomerulonephritis without immune deposits in the 
basement membrane. These lung and kidney specimen pathol-
ogies  were  consistent  with  pulmonary  and  renal  involvement 
of  MPA. 
The  differential  diagnosis  should  include  Goodpasture 
syndrome.  Goodpasture  syndrome  is  a  rare  but  severe  im-
munologic  disease,  which  is  characterized  by  rapidly  pro-
gressing  glomerulonephritis  and  diffuse  intraalveolar  hemor-
rhage  [1,2].  However,  in  our  case  there  was  immune  deposi-
tion  at  the  capillary  basement  membrane  [1],  so  we  could 
rule  out  Goodpasture  syndrome.Diffuse Alveolar Hemorrhage Due to MPA
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The  mainstay  of  treatment  of  MPA  is  systemic  cortico-
steroids and cyclophosphamide administration [3,6]. The treat-
ment duration of at least 12 months of combined therapy has 
been  recommended  based  on  empirical  research.  Few  papers 
have  studied  the  course  and  prognosis  of  pulmonary  involve-
m e n t  i n  M P A  [ 4 ] .  A l v e o l a r  h e m o r r h a g e  u s u a l l y  i m p r o v e s  
within  several  days  after  the  start  of  steroid  therapy  but  can 
continue  longer  [2,4]. 
We  describe  a  39-year-old  woman  presenting  with  a  pro-
gressive cough, dyspnea, and hemoptysis. We determined that 
her  condition was  MPA though  VATS lung  biopsy and renal 
biopsy.  After  2  months  of  steroid  therapy,  her  chest  lesions 
had  improved.  We  report  here  a  rare  case  of  MPA  with  iso-
lated and initial involvement of the lung, along with a review 
of  the  literature.
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